|
|
Exchange: |
Nasdaq National Market |
Security
Type: |
Common |
Shares
Out: |
13,870,000 |
Market
Cap: |
479.21(M) |
Last
Volume: |
380,999 |
Avg
Vol: |
64,972 |
52
Week Range: |
$17.67 - $38.49 |
|
Level
I Sector: |
Basic Materials |
Level
II Sector: |
Chemicals |
Level
III Sector: |
Specialty Chemicals |
|
Member Indexes:
|
S&P COMPOSITE 1500 |
|
NASDAQ COMPOSITE |
|
S&P SMALLCAP 600 |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Surmodics is a provider of surface modification technologies for intravascular medical devices and chemical components for in vitro diagnostic (IVD) immunoassay tests and microarrays. Co.'s segments are: Medical Device, which develops and manufactures vascular intervention medical device products and is engaged in Co.'s proprietary surface modification coating technologies that impart lubricity, pro-healing, biocompatibility characteristics, or drug-delivery capabilities to medical devices and delivery systems; and IVD, which manufactures and sells components for IVD immunoassay and molecular tests within the diagnostic, biomedical research, and life science markets.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
0 |
0 |
0 |
9,872 |
Total Sell Value |
$0 |
$0 |
$0 |
$335,339 |
Total People Sold |
0 |
0 |
0 |
3 |
Total Sell Transactions |
0 |
0 |
0 |
3 |
End Date |
2024-02-01 |
2023-10-31 |
2023-05-02 |
2022-05-02 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Maharaj Gary R |
President & CEO |
|
2021-10-01 |
4 |
AS |
$55.97 |
$336,097 |
D/D |
(6,000) |
152,811 |
|
-26% |
|
Kalich Ronald B Sr |
Director |
|
2021-09-30 |
4 |
A |
$55.60 |
$17,848 |
D/D |
321 |
25,339 |
|
- |
|
Dantzker David |
Director |
|
2021-09-30 |
4 |
A |
$55.60 |
$18,737 |
D/D |
337 |
30,821 |
|
- |
|
Maharaj Gary R |
President & CEO |
|
2021-09-15 |
4 |
AS |
$56.68 |
$343,359 |
D/D |
(6,000) |
158,811 |
|
-25% |
|
Arens Timothy J. |
Chief Financial Officer |
|
2021-08-31 |
4 |
D |
$60.07 |
$505,189 |
D/D |
(8,410) |
61,586 |
|
- |
|
Arens Timothy J. |
Chief Financial Officer |
|
2021-08-31 |
4 |
OE |
$23.95 |
$299,327 |
D/D |
12,498 |
69,996 |
|
- |
|
Olson Charles W |
Senior VP of Bus Dev, Med Dev |
|
2021-08-31 |
4 |
AS |
$59.75 |
$77,197 |
D/D |
(1,292) |
39,292 |
|
-22% |
|
Stich Joseph J. |
SVP, HR and GM, IVD |
|
2021-08-26 |
4 |
GD |
$0.00 |
$0 |
D/D |
1,500 |
45,314 |
|
- |
|
Stich Joseph J. |
SVP, HR and GM, IVD |
|
2021-08-24 |
4 |
D |
$56.14 |
$546,691 |
D/D |
(9,738) |
46,814 |
|
- |
|
Stich Joseph J. |
SVP, HR and GM, IVD |
|
2021-08-24 |
4 |
OE |
$21.03 |
$300,224 |
D/D |
14,276 |
56,552 |
|
- |
|
Stich Joseph J. |
SVP, HR and GM, IVD |
|
2021-08-19 |
4 |
AS |
$54.40 |
$136,002 |
D/D |
(2,500) |
42,276 |
|
-13% |
|
Manders John D. |
Corporate Controller |
|
2021-08-11 |
4 |
S |
$53.33 |
$139,136 |
D/D |
(2,608) |
3,108 |
|
13% |
|
Manders John D. |
Corporate Controller |
|
2021-08-11 |
4 |
OE |
$22.95 |
$59,854 |
D/D |
2,608 |
5,716 |
|
- |
|
Kalich Ronald B Sr |
Director |
|
2021-08-06 |
4 |
D |
$56.78 |
$94,425 |
D/D |
(1,663) |
25,018 |
|
- |
|
Kalich Ronald B Sr |
Director |
|
2021-08-06 |
4 |
OE |
$21.31 |
$94,403 |
D/D |
4,430 |
26,681 |
|
- |
|
Dantzker David |
Director |
|
2021-06-30 |
4 |
A |
$54.25 |
$18,716 |
D/D |
345 |
30,484 |
|
- |
|
Kalich Ronald B Sr |
Director |
|
2021-06-30 |
4 |
A |
$54.25 |
$17,848 |
D/D |
329 |
22,251 |
|
- |
|
Stich Joseph J. |
SVP, HR and GM, IVD |
|
2021-05-20 |
4 |
GD |
$0.00 |
$0 |
D/D |
1,000 |
44,776 |
|
- |
|
Stich Joseph J. |
SVP, HR and GM, IVD |
|
2021-05-20 |
4 |
AS |
$53.80 |
$134,506 |
D/D |
(2,500) |
45,776 |
|
4% |
|
Arens Timothy J. |
Chief Financial Officer |
|
2021-05-13 |
4 |
D |
$53.24 |
$7,134 |
D/D |
(134) |
57,498 |
|
- |
|
Weber Gordon S. |
Sr. VP of Legal, GC and Sec. |
|
2021-05-12 |
4 |
D |
$52.99 |
$15,473 |
D/D |
(292) |
6,955 |
|
- |
|
Olson Charles W |
Senior VP of Bus Dev, Med Dev |
|
2021-04-28 |
4 |
AS |
$59.75 |
$90,103 |
D/D |
(1,508) |
40,584 |
|
-1% |
|
Olson Charles W |
Senior VP of Bus Dev, Med Dev |
|
2021-04-16 |
4 |
AS |
$59.75 |
$38,718 |
D/D |
(648) |
42,092 |
|
-6% |
|
Olson Charles W |
Senior VP of Bus Dev, Med Dev |
|
2021-03-31 |
4 |
AS |
$56.75 |
$270,073 |
D/D |
(4,759) |
42,740 |
|
-3% |
|
Dantzker David |
Director |
|
2021-03-31 |
4 |
A |
$56.07 |
$18,727 |
D/D |
334 |
30,139 |
|
- |
|
573 Records found
|
|
Page 5 of 23 |
|
|